Non-invasive radiopharmaceutical imaging has been widely used during clinical management for numerous cancers and plays an essential role while achieving remarkable clinical outcomes.

Even in the early stages of some diseases, F-18 FDG is able to detect the status of glucose metabolism in the cells through molecular imaging technology, allowing physicians to conduct the most appropriate disease management.